Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023
Lloyd Price
NOVEMBER 25, 2023
Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.
Let's personalize your content